ARCHIVES

Group Chairmen Reject DCT’s Agenda For Clinical Trials Review, demand Right To Select Speakers

This article is from The Cancer Letter archive.

Vol. 04 No. 26 | June 30, 1978

Download PDF Visit The Full Archive

Related Articles

In Brief: UK Scientist Receives Pezcoller Award; Yale Appoints Associate Director for Trials

January 19, 1996

HHS Proposes Six New DRGs for Leukemia, Lymphoma

July 4, 1986

Cancer Prevention: Review Group’s Report Urges Integration Of Prevention with all NCI Research

June 27, 1997

NCI, Groups Disagree Over Recovery Of Funds In Cases of Scientific Fraud

October 7, 1994

ODAC Advice Poses Challenge to FDA: Would Iressa Approval Erode Standards?

November 8, 2002

Drug Shortages: Institutions Report Halting Enrollment in Clinical Trials

March 22, 2013